使用集成深度多模态框架的神经影像学数据告知情绪和精神病诊断

IF 3.3 2区 医学 Q1 NEUROIMAGING
Hooman Rokham, Haleh Falakshahi, Godfrey D. Pearlson, Vince D. Calhoun
{"title":"使用集成深度多模态框架的神经影像学数据告知情绪和精神病诊断","authors":"Hooman Rokham,&nbsp;Haleh Falakshahi,&nbsp;Godfrey D. Pearlson,&nbsp;Vince D. Calhoun","doi":"10.1002/hbm.70347","DOIUrl":null,"url":null,"abstract":"<p>Investigating neuroimaging data to identify brain-based markers of mental illnesses has gained significant attention. Nevertheless, these endeavors encounter challenges arising from a reliance on symptoms and self-report assessments in making an initial diagnosis. The absence of biological data to delineate nosological categories hinders the provision of additional neurobiological insights into these disorders. This study explores the use of neuroimaging to identify brain-based markers for mental illnesses, addressing the limitations of existing diagnoses. Previous research showed the potential of integrating structural neuroimaging data by treating diagnostic categories as uncertain and adjusting them to align better with biological data. Building on this, our current research incorporates multimodal neuroimaging data, combining fMRI with structural MRI, and introduces methodological advances to enhance diagnosis by creating more homogeneous categories based on MRI-derived neurobiological information. Unlike other studies that reclassify psychiatric groups purely based on biological data, our approach integrates neuroimaging and symptom-based categories using ensemble methods, deep learning, and data fusion. This strategy aims to improve symptom-based categorization by identifying biologically-based categories that help distinguish between correctly classified, challenging, and noisy samples. Our goals include identifying potential biomarkers for existing symptom-based categories, determining biologically homogeneous groups, and mitigating label noise across mood and psychosis categories. We analyzed the relationship between biological findings and existing categories, highlighting discrepancies between brain imaging features and symptom-based categories, and assessing the potential of augmenting label categories for sample heterogeneity. Notably, visualization techniques provided insights into distinct brain patterns in well-classified versus challenging samples. We used a deep convolutional framework and bagging approaches for diagnostic classification, finding that ensemble deep models outperformed individual models, and multimodal frameworks consistently surpassed unimodal approaches. In sum, this work highlights the potential of combining existing symptom-based categorization with multimodal data and advanced data-driven approaches to improve the categorization of mental illness.</p>","PeriodicalId":13019,"journal":{"name":"Human Brain Mapping","volume":"46 13","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hbm.70347","citationCount":"0","resultStr":"{\"title\":\"Neuroimaging Data Informed Mood and Psychosis Diagnosis Using an Ensemble Deep Multimodal Framework\",\"authors\":\"Hooman Rokham,&nbsp;Haleh Falakshahi,&nbsp;Godfrey D. Pearlson,&nbsp;Vince D. Calhoun\",\"doi\":\"10.1002/hbm.70347\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Investigating neuroimaging data to identify brain-based markers of mental illnesses has gained significant attention. Nevertheless, these endeavors encounter challenges arising from a reliance on symptoms and self-report assessments in making an initial diagnosis. The absence of biological data to delineate nosological categories hinders the provision of additional neurobiological insights into these disorders. This study explores the use of neuroimaging to identify brain-based markers for mental illnesses, addressing the limitations of existing diagnoses. Previous research showed the potential of integrating structural neuroimaging data by treating diagnostic categories as uncertain and adjusting them to align better with biological data. Building on this, our current research incorporates multimodal neuroimaging data, combining fMRI with structural MRI, and introduces methodological advances to enhance diagnosis by creating more homogeneous categories based on MRI-derived neurobiological information. Unlike other studies that reclassify psychiatric groups purely based on biological data, our approach integrates neuroimaging and symptom-based categories using ensemble methods, deep learning, and data fusion. This strategy aims to improve symptom-based categorization by identifying biologically-based categories that help distinguish between correctly classified, challenging, and noisy samples. Our goals include identifying potential biomarkers for existing symptom-based categories, determining biologically homogeneous groups, and mitigating label noise across mood and psychosis categories. We analyzed the relationship between biological findings and existing categories, highlighting discrepancies between brain imaging features and symptom-based categories, and assessing the potential of augmenting label categories for sample heterogeneity. Notably, visualization techniques provided insights into distinct brain patterns in well-classified versus challenging samples. We used a deep convolutional framework and bagging approaches for diagnostic classification, finding that ensemble deep models outperformed individual models, and multimodal frameworks consistently surpassed unimodal approaches. In sum, this work highlights the potential of combining existing symptom-based categorization with multimodal data and advanced data-driven approaches to improve the categorization of mental illness.</p>\",\"PeriodicalId\":13019,\"journal\":{\"name\":\"Human Brain Mapping\",\"volume\":\"46 13\",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2025-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hbm.70347\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Human Brain Mapping\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/hbm.70347\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"NEUROIMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human Brain Mapping","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hbm.70347","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"NEUROIMAGING","Score":null,"Total":0}
引用次数: 0

摘要

通过研究神经成像数据来识别基于大脑的精神疾病标志物已经引起了极大的关注。然而,这些努力遇到了挑战,因为在进行初步诊断时依赖症状和自我报告评估。缺乏描述疾病分类的生物学数据阻碍了对这些疾病提供额外的神经生物学见解。本研究探索使用神经影像学来识别基于大脑的精神疾病标志物,解决现有诊断的局限性。先前的研究表明,通过将诊断类别视为不确定并对其进行调整以更好地与生物学数据保持一致,整合结构神经影像学数据的潜力。在此基础上,我们目前的研究结合了多模态神经成像数据,将功能磁共振成像与结构磁共振成像相结合,并引入了方法上的进步,通过基于MRI衍生的神经生物学信息创建更均匀的分类来增强诊断。与其他纯粹基于生物学数据对精神病学群体进行重新分类的研究不同,我们的方法使用集成方法、深度学习和数据融合,将神经影像学和基于症状的分类整合在一起。该策略旨在通过识别基于生物学的分类来改进基于症状的分类,这些分类有助于区分正确分类、具有挑战性和有噪声的样本。我们的目标包括确定现有基于症状的类别的潜在生物标志物,确定生物同质组,以及减轻情绪和精神病类别之间的标签噪音。我们分析了生物学发现与现有分类之间的关系,强调了脑成像特征与基于症状的分类之间的差异,并评估了增加样本异质性标签分类的潜力。值得注意的是,可视化技术提供了对分类良好和具有挑战性的样本的不同大脑模式的见解。我们使用深度卷积框架和bagging方法进行诊断分类,发现集成深度模型优于单个模型,多模态框架始终优于单模态方法。总之,这项工作强调了将现有的基于症状的分类与多模态数据和先进的数据驱动方法相结合的潜力,以改善精神疾病的分类。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Neuroimaging Data Informed Mood and Psychosis Diagnosis Using an Ensemble Deep Multimodal Framework

Neuroimaging Data Informed Mood and Psychosis Diagnosis Using an Ensemble Deep Multimodal Framework

Investigating neuroimaging data to identify brain-based markers of mental illnesses has gained significant attention. Nevertheless, these endeavors encounter challenges arising from a reliance on symptoms and self-report assessments in making an initial diagnosis. The absence of biological data to delineate nosological categories hinders the provision of additional neurobiological insights into these disorders. This study explores the use of neuroimaging to identify brain-based markers for mental illnesses, addressing the limitations of existing diagnoses. Previous research showed the potential of integrating structural neuroimaging data by treating diagnostic categories as uncertain and adjusting them to align better with biological data. Building on this, our current research incorporates multimodal neuroimaging data, combining fMRI with structural MRI, and introduces methodological advances to enhance diagnosis by creating more homogeneous categories based on MRI-derived neurobiological information. Unlike other studies that reclassify psychiatric groups purely based on biological data, our approach integrates neuroimaging and symptom-based categories using ensemble methods, deep learning, and data fusion. This strategy aims to improve symptom-based categorization by identifying biologically-based categories that help distinguish between correctly classified, challenging, and noisy samples. Our goals include identifying potential biomarkers for existing symptom-based categories, determining biologically homogeneous groups, and mitigating label noise across mood and psychosis categories. We analyzed the relationship between biological findings and existing categories, highlighting discrepancies between brain imaging features and symptom-based categories, and assessing the potential of augmenting label categories for sample heterogeneity. Notably, visualization techniques provided insights into distinct brain patterns in well-classified versus challenging samples. We used a deep convolutional framework and bagging approaches for diagnostic classification, finding that ensemble deep models outperformed individual models, and multimodal frameworks consistently surpassed unimodal approaches. In sum, this work highlights the potential of combining existing symptom-based categorization with multimodal data and advanced data-driven approaches to improve the categorization of mental illness.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Human Brain Mapping
Human Brain Mapping 医学-核医学
CiteScore
8.30
自引率
6.20%
发文量
401
审稿时长
3-6 weeks
期刊介绍: Human Brain Mapping publishes peer-reviewed basic, clinical, technical, and theoretical research in the interdisciplinary and rapidly expanding field of human brain mapping. The journal features research derived from non-invasive brain imaging modalities used to explore the spatial and temporal organization of the neural systems supporting human behavior. Imaging modalities of interest include positron emission tomography, event-related potentials, electro-and magnetoencephalography, magnetic resonance imaging, and single-photon emission tomography. Brain mapping research in both normal and clinical populations is encouraged. Article formats include Research Articles, Review Articles, Clinical Case Studies, and Technique, as well as Technological Developments, Theoretical Articles, and Synthetic Reviews. Technical advances, such as novel brain imaging methods, analyses for detecting or localizing neural activity, synergistic uses of multiple imaging modalities, and strategies for the design of behavioral paradigms and neural-systems modeling are of particular interest. The journal endorses the propagation of methodological standards and encourages database development in the field of human brain mapping.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信